The Global Lung Cancer Therapeutics Market was worth $5.65 billion in 2016 and estimated to be growing at a CAGR of 6.7%, to reach $7.81 billion by 2021.
High blood levels of alpha-tocopherol or gamma-tocopherol, (vitamin E forms), cut risk of prostate cancer 50% in new analysis of ATBC trial, supporting original conclusions. Dietary, but not supplementary, vitamin E, is key.